NovoCure
(NASDAQ:NVCR)
$12.0644
0.0094[0.08%]
At close: Apr 24
$12.0644
0[0.00%]
PreMarket: 7:30AM EDT
Q1 2024 Earnings in 8 days from now on Thu May 2nd, before the market open

NovoCure Stock (NASDAQ:NVCR), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Date Announced
▲▼
ticker
▲▼
Company Name
▲▼
Period
▲▼
Period Year
▲▼
Min EPS
▲▼
Max EPS
▲▼
Estimate
▲▼
Min Rev
▲▼
Max Rev
▲▼
Revenue Estimate
▲▼
Get Alert
01/08/2024NVCR
NovoCure
FY2023———$509.30M$509.30M$505.05MGet Alert
01/08/2024NVCR
NovoCure
Q42023———$133.80M$133.80M$129.30MGet Alert
01/09/2023NVCR
NovoCure
FY2022———$537.80M$537.80M$538.28MGet Alert
01/09/2023NVCR
NovoCure
Q42022———$128.40M$128.40M$129.14MGet Alert
01/10/2022NVCR
NovoCure
FY2021———$535.00M$535.00M$539.23MGet Alert
01/10/2022NVCR
NovoCure
Q42021———$133.20M$133.20M$137.36MGet Alert
01/11/2021NVCR
NovoCure
Q42020———$144.00M$144.00M$133.26MGet Alert
01/11/2021NVCR
NovoCure
FY2020———$494.40M$494.40M$482.29MGet Alert
01/13/2020NVCR
NovoCure
Q42019———$99.20M$99.20M$95.65MGet Alert
01/13/2020NVCR
NovoCure
FY2019———$351.30M$351.30M$347.69MGet Alert

FAQ

Q

What is the most recent guidance for NovoCure (NVCR)?

A

There have been no specific sales or earnings guidance reported for NovoCure in recent months.

Browse guidance and forecast on all stocks.

People Also Watch